In addition, breast cancer cell lines with low levels of EGFR expression were sensitive to GEF when they co-expressed high levels of EGFR2, and this effect is due to the GEF-induced reduction of EGFR1/EGFR2 heterodimerization [37, 97, 145]. This evidence concerns the gene EGFR and breast cancer.